Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -14.23% vs 11.70% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -15.93% vs 6.43% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 30.07% vs -63.52% in Sep 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -75.00% vs 100.00% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Sep 2025
Compare Quarterly Results Of Zhejiang Shengda Bio-Pharm Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -14.23% vs 11.70% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -6.89% vs 9.96% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -15.93% vs 6.43% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -34.62% vs 341.51% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 30.07% vs -63.52% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -57.63% vs 96.86% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -75.00% vs 100.00% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -66.67% vs -50.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Sep 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






